Ibudilast in the Treatment of Medication Overuse Headache: A Double-blind, Randomised, Placebo-controlled Pilot Study.

Trial Profile

Ibudilast in the Treatment of Medication Overuse Headache: A Double-blind, Randomised, Placebo-controlled Pilot Study.

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Ibudilast (Primary)
  • Indications Secondary headache disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Feb 2013 Planned end date changed from 1 Dec 2011 to 1 Aug 2013 as reported by ClinicalTrials.gov.
    • 13 Mar 2012 This trial is ongoing, according to a MediciNova media release.
    • 26 Oct 2011 Trial phase changed from I to I/II as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top